US Private Equity Firm SK Capital Nears Swixx Biopharma
The Swixx Biopharma acquisition deal represents a significant move for SK Capital Partners as it seeks to expand its presence in the European healthcare sector.
Amgen drug discounts Launch for Cash-Paying Patients After
Amgen drug discounts aim to make medications more affordable by offering rebates to cash-paying patients, reflecting a broader industry effort to improve drug